
The Wall Street Journal @WSJ
Johnson & Johnson is curtailing production of its Covid-19 vaccine in the face of slumping demand. The company is also in arbitration with rival Merck over a partnership to make the shot. https://t.co/BCwI5SiqXg — PolitiTweet.org